- Home
- IKNA vs MGLD Comparison
IKNA vs MGLD Comparison
Compare IKNA & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- MGLD
- Stock Information
- Founded
- IKNA 2016
- MGLD 1996
- Country
- IKNA United States
- MGLD United States
- Employees
- IKNA N/A
- MGLD N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- IKNA Health Care
- MGLD Finance
- Exchange
- IKNA Nasdaq
- MGLD Nasdaq
- Market Cap
- IKNA 74.8M
- MGLD 59.9M
- IPO Year
- IKNA 2021
- MGLD N/A
- Fundamental
- Price
- IKNA $1.57
- MGLD $1.74
- Analyst Decision
- IKNA Buy
- MGLD
- Analyst Count
- IKNA 2
- MGLD 0
- Target Price
- IKNA $3.00
- MGLD N/A
- AVG Volume (30 Days)
- IKNA 399.7K
- MGLD 14.1K
- Earning Date
- IKNA 11-07-2024
- MGLD 02-12-2025
- Dividend Yield
- IKNA N/A
- MGLD N/A
- EPS Growth
- IKNA N/A
- MGLD N/A
- EPS
- IKNA N/A
- MGLD N/A
- Revenue
- IKNA $659,000.00
- MGLD $32,511,000.00
- Revenue This Year
- IKNA N/A
- MGLD N/A
- Revenue Next Year
- IKNA N/A
- MGLD N/A
- P/E Ratio
- IKNA N/A
- MGLD N/A
- Revenue Growth
- IKNA N/A
- MGLD N/A
- 52 Week Low
- IKNA $1.22
- MGLD $0.78
- 52 Week High
- IKNA $2.17
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- IKNA 42.72
- MGLD 57.28
- Support Level
- IKNA $1.62
- MGLD $1.32
- Resistance Level
- IKNA $1.94
- MGLD $2.10
- Average True Range (ATR)
- IKNA 0.10
- MGLD 0.21
- MACD
- IKNA -0.01
- MGLD 0.03
- Stochastic Oscillator
- IKNA 16.85
- MGLD 58.62
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.